Sort
23,748 grants matching “melanoma”
Development of a protein drug for pancreatic cancer treatment
$999,780Zhi-Ren Liu · Proda Biotech, Llc · R42 · FY2018 · CA
Development of a protein drug for pancreatic cancer treatment
$999,780Zhi-Ren Liu · Proda Biotech, Llc · R42 · FY2019 · CA
Induction of an Antitumor Immune Response in Patients with Melanoma
$999,555Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer
$999,501Upendra Marathi · 7 Hills Pharma, Llc · R42 · FY2018 · CA
SUNNY DAYS HEALTHY WAYS GRADES 6-8 SUN SAFETY CURRICULUM
$999,462Amc Cancer Research Center · R01 · FY2000 · CA
Fluorescein for Sentinel Lymph Node Detection
$999,419James M McGreevy · Vestan, Inc. · R42 · FY2010 · CA
Liver Specific Manganese Based MRI Contrast Agent
$999,330Vera Hoffman · Reveal Pharma · R44 · FY2021 · CA
PyroTIMER Technology: Enabling T-Cell Persistence in Immunosuppressive Tumor Microenvironments
$999,283Archis Bagati · Pyrojas Inc · R44 · FY2025 · CA
7HP349, an Integrin Activator to Treat Patients With anti-PD-1 Resistant Solid Tumors
$999,200Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2023 · CA
7HP349, an Integrin Activator to Treat Patients With anti-PD-1 Resistant Solid Tumors
$999,200Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2024 · CA
Development of GIFT4: a B cell focused immunotherapy for cancer
$999,088Paul Guyre · Celdara Medical, Llc · R44 · FY2017 · CA
A Molecular Diagnostic Assay for Accurately Differentiating Melanoma from Benign Lesions
$998,671David L Hachey · Frontier Diagnostics, Llc · R44 · FY2019 · CA
Illinois Oncology Research Association Community Clinical Oncology Program
$998,654John W Kugler · Oncology-Hematology Assoc-Central Ill · U10 · FY2009 · CA
Induction of an Antitumor Immune Response in Patients with Melanoma
$998,246Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
$996,661Mark Reid Philips · New York University School Of Medicine · R35 · FY2022 · CA
Biology and genetics of metastatic disease
$996,660Sohail F. Tavazoie · Rockefeller University · R35 · FY2023 · CA
Immunomodulatory Therapy for Neuropathic Pain
$996,399Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2021 · NS
Liver Specific Manganese Based MRI Contrast Agent
$996,175Vera Hoffman · Reveal Pharma · R44 · FY2020 · CA
Reprogramming of T cells for the Treatment of Melanoma
$995,664Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Reprogramming of T cells for the Treatment of Melanoma
$995,664Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Reprogramming of T cells for the Treatment of Melanoma
$995,664Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Fluorescein for Sentinel Lymph Node Detection
$995,474James M McGreevy · Vestan, Inc. · R42 · FY2012 · CA
3D Bioprinted skin models for drug screening
$994,550Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
A novel immuno-oncolytic viral therapy for the treatment of non-small cell lung carcinoma
$994,294Stephen H Thorne · Western Oncolytics, Ltd · R44 · FY2020 · CA
Regulation of Lymphocyte Proliferation and Replicative Capacity
$993,254Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA